مقایسهٔ روش‌ها

	مدل‌سازی همولوگ	مدل‌سازی فارماکوفور	QSAR
حوزه	زیست‌اطلاعاتی	زیست‌اطلاعاتی	زیست‌اطلاعاتی
خانواده	Process / pipeline	Process / pipeline	Process / pipeline
سال پیدایش	1993	1977	1964
پدیدآور	Andrej Sali	Peter Gund	Corwin Hansch
نوع	Comparative structure prediction pipeline	Pattern-based virtual screening pipeline	Regression-based predictive modeling pipeline
منبع بنیادین	Sali, A. & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology, 234(3), 779-815.	Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998). Glossary of terms used in medicinal chemistry. Pure and Applied Chemistry, 70(5), 1129-1143.	Hansch, C. & Fujita, T. (1964). Rho-sigma-pi analysis. A method for the correlation of biological activity and chemical structure. Journal of the American Chemical Society, 86(8), 1616-1626.
نام‌های دیگر	comparative modeling, template-based modeling	pharmacophore pattern recognition, 3D pharmacophore	QSAR model, quantitative structure-activity relationship
مرتبط	4	3	3
خلاصه	Homology modeling, also called comparative modeling, predicts the three-dimensional structure of a protein using an experimentally-solved structure of a homologous protein as a template. Introduced by Sali and Blundell in 1993, this method exploits the principle that homologous proteins share similar spatial structures despite differing in amino acid sequence.	Pharmacophore modeling identifies the spatial arrangement of molecular features (hydrogen bond donors, acceptors, aromatic rings) that are essential for biological activity. Introduced by Gund in 1977, this ligand-based method creates a three-dimensional pattern that can screen chemical libraries and design new active compounds without requiring receptor structure.	Quantitative Structure-Activity Relationship (QSAR) modeling predicts biological activity from molecular structure using statistical or machine learning models. Pioneered by Hansch in 1964, QSAR correlates numerical molecular descriptors with measured bioactivity, enabling prediction of activity for untested compounds and rational lead optimization.